The Occurrence of Atrial Fibrillation After Totally Endoscopic Cardiac Surgery

Jessa Hospital1 site in 1 country152 target enrollmentMarch 22, 2023

ConditionsAtrial Fibrillation

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Atrial Fibrillation
Sponsor: Jessa Hospital
Enrollment: 152
Locations: 1
Primary Endpoint: The occurence of new-onset postoperative atrial fibrillation using constant electrocardiogram monitoring and photoplethysmography (FibriCheck)
Status: Terminated
Last Updated: last year

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The aim of this study is to investigate the occurrence of new-onset postoperative atrial fibrillation after totally endoscopic cardiac surgery.

Registry

clinicaltrials.gov

Start Date

March 22, 2023

End Date

November 9, 2024

Last Updated

last year

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

Jessa Hospital

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•\>18 years old
•Patients undergoing elective endoscopic cardiac surgery (totally endoscopic coronary artery bypass grafting or endoscopic valve replacement)

Exclusion Criteria

•Preoperative atrial fibrillation
•Patients that do not understand Dutch or French or English
•Patients that do not have a smartphone
•Concomitant or redo surgeries

Outcomes

Primary Outcomes

The occurence of new-onset postoperative atrial fibrillation using constant electrocardiogram monitoring and photoplethysmography (FibriCheck)

Time Frame: Until 30 days postoperatively

New-onset postoperative atrial fibrillation will be detected until 30 days postoperatively. Constant electrocardiogram monitoring is performed at the intensive care unit (ICU). After dismissal from the ICU, the FibriCheck application is used to detect atrial fibrillation using photoplethysmography. Patients need to use the application three times a day and when symptoms are present.